ADVERTISEMENT

Titan's MD CK Venkataraman On Q1 Results & FY22 Growth Trajectory

Titan's MD CK Venkataraman On Q1 Results & FY22 Growth Trajectory

Titan's MD CK Venkataraman On Q1 Results & FY22 Growth Trajectory
Titan's MD CK Venkataraman On Q1 Results & FY22 Growth Trajectory
Titan managed to surpass estimates in Q1 even as localised-lockdowns impacted sales. MD CK Venkataraman is confident of improved financials in FY22. Here's why. #Q1WithBQ